These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20105164)

  • 21. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
    Stark KD; Park EJ; Holub BJ
    Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
    Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
    Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifetime endogenous estrogen exposure and electrocardiographic frontal T axis changes in postmenopausal women.
    Atsma F; van der Schouw YT; Grobbee DE; Kors JA; Bartelink ML
    Maturitas; 2009 Aug; 63(4):347-51. PubMed ID: 19570627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status.
    Kanaley JA; Sames C; Swisher L; Swick AG; Ploutz-Snyder LL; Steppan CM; Sagendorf KS; Feiglin D; Jaynes EB; Meyer RA; Weinstock RS
    Metabolism; 2001 Aug; 50(8):976-82. PubMed ID: 11474488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leisure, home, and occupational physical activity and cardiovascular risk factors in postmenopausal women. The Postmenopausal Estrogens/Progestins Intervention (PEPI) Study.
    Greendale GA; Bodin-Dunn L; Ingles S; Haile R; Barrett-Connor E
    Arch Intern Med; 1996 Feb; 156(4):418-24. PubMed ID: 8607727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study.
    Shakir YA; Samsioe G; Khatibi E A; Nyberg P; Lidfeldt J; Agardh CD; Nerbrand C
    J Womens Health (Larchmt); 2007 Apr; 16(3):406-14. PubMed ID: 17439385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of atherogenetic biomarkers and estradiol changes in postmenopause.
    Ratiani L; Parkosadze G; Koptonashvili L; Ormotsadze G; Sulaqvelidze M; Sanikidze T
    Georgian Med News; 2011 Jun; (195):100-5. PubMed ID: 21778553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term estrogen replacement therapy reduces platelet marker levels in Malaysian postmenopausal women.
    Sheikh SA; Roshan TM; Khattak MN; Baig AA; Noor SJ; Hassan R; Zaki NM
    Menopause Int; 2011 Mar; 17(1):6-10. PubMed ID: 21427417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen replacement therapy, subsyndromal depression, and orthostatic blood pressure regulation.
    Canada SA; Hofkamp M; Gall EP; Perlmuter LC
    Behav Med; 2003; 29(3):101-6. PubMed ID: 15206828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.
    Buller JC; Kritz-Silverstein D; Barrett-Connor E; Wingard D
    J Womens Health; 1998 Feb; 7(1):49-56. PubMed ID: 9511132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.
    Xu Y; Lin J; Wang S; Xiong J; Zhu Q
    Kaohsiung J Med Sci; 2014 Jul; 30(7):350-61. PubMed ID: 24924841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased umbilical orexin-A level is associated with idiopathic polyhydramnios.
    Cho GJ; Hong HR; Kim SW; Hong SC; Oh MJ; Kim HJ
    Acta Obstet Gynecol Scand; 2015 Mar; 94(3):295-300. PubMed ID: 25494826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women.
    Nansseu JR; Moor VJ; Nouaga ME; Zing-Awona B; Tchanana G; Ketcha A
    Lipids Health Dis; 2016 Mar; 15():49. PubMed ID: 26957313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute post-bariatric surgery increase in orexin levels associates with preferential lipid profile improvement.
    Gupta A; Miegueu P; Lapointe M; Poirier P; Martin J; Bastien M; Tiwari S; Cianflone K
    PLoS One; 2014; 9(1):e84803. PubMed ID: 24400115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.